Double-blind, placebo-controlled first in human study to investigate an oral vaccine aimed to elicit an immune reaction against the VEGF-Receptor 2 in patients with stage IV and locally advanced pancreatic cancer - Niethammer, Andreas Gerhard; Mikus, Gerd; Knebel, Phillip; Hohmann, Nicolas; Leowardi-Bauer, Christine; Beckhove, Philipp; Akhisaroglu, Mustafa; Ge, Yingzi; Grenacher, Lars; Büchler, Markus W.; Koch, Moritz; Weitz, Jürgen; et al. (BMC cancer, 2012)
Gesehen am 28.08.2018